Related Experiment Video
Updated: Mar 6, 2026
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
miR-155 as a potential target of IL-3 signaling in primary AML cells
Teresa Sadras1, Chung H Kok1, Michelle Perugini1
1Division of Haematology, Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia; School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia, Australia.
Abstract:
miR-155 has emerged as one of the key microRNAs (miRNAs) involved in normal and malignant myelopoiesis, and high expression of this miRNA has been flagged as a strong independent prognostic marker in Acute Myeloid Leukemia (AML). While elevated expression of miR-155 has been associated with FLT3-ITD mutations, other mechanisms which may regulate expression of this miRNA in AML remain largely unknown. Here, we present new evidence that miR-155 may be a prime target of IL-3 signaling in primary AML cells. This finding, together with the increasingly apparent role for miR-155 in oncogenesis, and the upregulation of the IL-3 receptor alpha subunit in AML, lead us to propose this pathway may significantly contribute to the leukemic transformation.
Insights
MicroRNA-155 (miR-155) is a key player in Acute Myeloid Leukemia (AML). New research suggests Interleukin-3 (IL-3) signaling regulates miR-155 in AML, potentially contributing to leukemic transformation.
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer.
- miR-155 is a significant prognostic marker in Acute Myeloid Leukemia (AML).
- Elevated miR-155 expression in AML is linked to FLT3-ITD mutations, but regulatory mechanisms are unclear.
Discussion:
- This study reveals miR-155 as a potential target of Interleukin-3 (IL-3) signaling in primary AML cells.
- The IL-3 receptor alpha subunit is upregulated in AML, suggesting a role for this pathway.
- The interplay between IL-3 signaling and miR-155 may be crucial for leukemic transformation.
Key Insights:
- IL-3 signaling directly influences miR-155 expression in AML.
- This pathway represents a novel mechanism regulating a key oncomiR in leukemia.
- Findings highlight the IL-3/miR-155 axis as a potential therapeutic target in AML.
Outlook:
- Further investigation into the IL-3/miR-155 pathway could uncover new therapeutic strategies for AML.
- Understanding this signaling axis may lead to improved diagnostic or prognostic tools.
- This research opens avenues for targeting miRNA regulation in myeloid malignancies.
